Skip to main content

23andMe set to go public via a Virgin Group SPAC merger

By TechCrunch  
   February 04, 2021

Genetics testing and genome research company 23andMe is set to go public via a merger with special purpose acquisition corp (SPAC) VG Acquisition Corp, a vehicle set up by Richard Branson and his company Virgin Group. The transaction is expected to result in 23andMe having around $984 million in cash available at close to spend on product development, hires and other growth strategies, and will value the company at around $3.5 billion, close to the total cited by an earlier report detailing the talks leading up to this deal.

Full story


Get the latest on healthcare leadership in your inbox.